Clinical Trial Update: Use of Methacetin Breath Test to Predict Liver Failure in Patients With Cirrhosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the methacetin breath test to predict liver failure in patients with cirrhosis has completed and results are posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis

Drugs mentioned

• Methacetin Breath Test (methacetin breath test)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Cirrhosis | Phase 3 | Status: COMPLETED | Results posted: 2014-03-04